EMA
approval
· 2015-06-26
First treatment recommended for rare bone disease
Summary
EMA recommends the first treatment for a rare bone disease, marking a pivotal step toward an approved therapy for the condition.
Upgrade for the full analysis, importance score, and drug timeline.